According to the research report titled ‘Global Heart Valve Devices Market Analysis, 2020’, available with Market Study Report, global heart valve devices market is predicted to record 14% CAGR during 2020-2025.
 

The report states that global heart valve devices market growth is driven by surging popularity of minimally invasive surgeries, in consort with irregular eating habits resulting in increasing number of cholesterol and obesity cases, and rising acceptance of sedentary lifestyle. In addition, booming elderly population, escalating pervasiveness of congenital heart defects (CHD), and launch of innovative cardiac valve devices are also adding to the market valuation. 
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3114532/
 

Apart from these factors, mounting demand for transcatheter devices and increasing expenditure in healthcare infrastructure are anticipated to further augment worldwide heart valve devices industry share over the analysis timeframe.
 

Besides containing a descriptive analysis of the key growth drivers, global heart valve devices market documentation highlights critical information concerning the challenges and opportunities in this business domain. It also contains a comparative study of the past records and the current market trends to derive the growth rate of this business sphere over 2020-2025. Also, it envelops the business strategies adopted by the major players to sustain the fierce competition.
 

Based on product landscape, worldwide heart valve devices market is split into tissue/bio-prosthetic valves (tricuspid valves, pulmonary valves, aortic valves, and mitral valves), mechanical valves (aortic valves, and mitral valves), transcatheter valves (pulmonary valves, aortic valves, and mitral valves).
 

As per procedure, the industry is divided into heart valve repair devices, and heart valve replacement devices.
 

Speaking of end user scope, the market is classified into ambulatory surgical centers, specialty centers, and hospitals. The hospitals segment held a major portion of global heart valve devices industry share in 2019, on account of evolving healthcare reimbursement structure in developing and developed economies, escalating number of heart disorders, enhancements in quality of medical services, and surging investment towards healthcare infrastructure.
 

Considering the regional landscape, Asia Pacific, Middle East & Africa, Europe, South America, and North America are the regions considered for global heart valve devices market analysis.
 

Major companies influencing global heart valve devices industry trends are On-X Life Technologies Inc., Meril Life Sciences Pvt. Ltd., Venus MedTech HangZhou Inc., LivaNova plc, Micro Interventional Devices Inc., Neovasc Inc., Medtronic plc, Novostia SA, Lepu Medical Technology (Beijing) Co. Ltd., Abbott Laboratories, Edward Lifesciences Corporation, Boston Scientific Corporation, TTK Healthcare Ltd., Xeltis AG, and JenaValve Technology Inc.